Sanofi sells 20 drugs and three sites to Cheplapharm to focus on innovation
Sanofi announces the sale of 20 mature drugs and three production sites to Germany's Cheplapharm.
Published 2h1 sourceNotable
Lire en français
≈ 21s
The fact
The deal, completed on September 14, includes a 26.4% stake in Cheplapharm.
The French group is accelerating its shift toward innovative treatments and biotechnologies.
Click the link to read an article on the topic: